The CEO of ΜΥΟ was appointed Expert Advisor to the European Commission for the evaluation of Medical Technology


The CEO of ΜΥΟ was appointed Expert Advisor to the European Commission for the evaluation of Medical Technologies for years 2018 and 2019. In this advisory role, Dr Ouzounelli will be evaluating proposals requesting EU funding for the development and commercialization of innovative medical technologies (drugs or devices), as part of the Horizon-2020 funding program. Horizon-2020 will be investing 1.6 billion Euros in hi-tech funding over the period 2018-2020.